Form EFFECT Cocrystal Pharma, Inc.
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | May 1, 2026 4:30 P.M. |
| Form: | S-3 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Why Traders Are Turning to Zervulkait for Smarter Market Analysis
- Zehl & Associates Named National Finalist for 2026 Elite Trial Lawyers Award in Catastrophic Injury
- Avetta Connects a Trusted, Ready-to-Work Community Across Global Supply Chains
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
